My Lemtrada Journey: Round 2, Plus 7 Months
I’m coming up on the second anniversary of my Lemtrada (alemtuzumab) treatment. My first infusion round was the…
Articles by Ed Tobias
FDA Warns of Possible Dangers of Stopping Gilenya
If you are being treated with Gilenya, take note. The U.S. Food and Drug Administration is warning that if…
Can’t Afford Health Insurance for Your Family? Who Do You Cut?
We all know how expensive health insurance can be. On the social media sites that I browse, I always…
MS News that Caught My Eye Last Week: New Thinking About MS Development, Rhythm to Improve Walking, UK Nurse Shortage, B-cells
MS-specific Lineage of Oligodendrocytes May Provide New Hints on MS Development Our immune system, according to this…
When You’ve Gotta Go, but There’s No Place to Do It
We’ve all been there. That “uh-oh” feeling hits and you know you’ll be in trouble if you can’t find…
I Know I’m in a Handicapped Spot, but I’ll Only Be 2 Minutes
I’m writing again about someone with MS who was blocked from a handicapped parking spot by someone who…
MS News that Caught My Eye Last Week: Ballet and MS, Salt and the Immune System, How Tecfidera May Work, Doctor-Patient Communications
Exercise Program Based on Ballet Improves Motor Control and Balance in MS Patients, Study Reports It makes…
MS, a Foot Brace, and a Car Crash
A tragic car crash involving a man with MS is a reminder that we all should be just a…
MS Medications in Mexico: Insurer Encourages Patients to Go South
MS medications are expensive in the United States. We all know that. We also know that some of those…
MS News that Caught My Eye Last Week: Ocrevus in the UK, Environmental Triggers, PPMS Research
NICE Postpones Final Opinion on Adding Ocrevus to Public Health System for PPMS Patients in UK This…
MS and the Flu Shot: What If You Don’t Want One?
I’ve written several times about MS and the flu. I’ve always encouraged people to get an annual flu…
Thinking About Selma Blair and Her MS
By now you may have heard that actress Selma Blair has revealed that she has multiple sclerosis (MS).
MS News that Caught My Eye Last Week: Cannabis Pill, Stem Cells in Outer Space, Gut Bacteria and T-cells, Herpes and MS
Stanford Researchers Open Medical Cannabis Company with Oral Therapy for MS Pain, Spasticity as Initial Goal Let’s…
FTC Challenges Amniotic Stem Cell Treatment Clinics’ Claims
“Deceptive” and “false” are two words used by the U.S. Federal Trade Commission (FTC) to describe marketing claims by two…
New Rules May Bring Updated Rights to Flyers with Disabilities
Flying isn’t what it used to be, as everyone who’s taken a flight in the past 15 years or…
I’m Too Tired to Write Tonight
Please forgive me, but I’m too tired to write tonight. My wife had surgery last week, so I’ve been…
MS Patients Capture the Ear of a Pharma Company
People with multiple sclerosis (MS) rarely get the opportunity to talk to the people who design their medications. But…
Buddy, Can You Give Me a Lift to the Doctor?
Is getting from home to a healthcare appointment a pain in the butt for you? Do you have to…
MS News that Caught My Eye Last Week: aHSCT and Fatigue, What’s Hot at ECTRIMS?, Genes that May Impact MS
Lower Fatigue Reported by MS Patients After aHSCT in Canadian Study Fatigue affects 90 percent of people…
Could Government Probe Threaten Pharma Patient Assistance Programs?
Many of us have received help to pay for our MS medications. Now there’s a chance that assistance could…
MS Patient Argues Over Where She Had Parked — And Won!
We all know how difficult it can be to find an accessible parking spot — one that allows us…
MS News that Caught My Eye Last Week: MRI Signal, Cost-effective DMTs, Age Benefits, Generic Ampyra
Often-overlooked MRI Signal May Aid in Early Diagnosis of MS, Other Brain Conditions, Study Suggests A part…
Serious DMTs Need Serious Care Coordination
Ocrevus (ocrelizumab) is a serious disease-modifying therapy. It has the potential to deliver a major blow to a…
Wearables Focus on Tracking Your Health
I never thought I’d want a wearable internet device until I got an Apple Watch for my birthday. One…
MS News that Caught My Eye Last Week: Treating MS with a Statin, Ocrevus, Remyelination
Phase 3 Trial in the UK Soon to Test Statin, Simvastatin, in Slowing SPMS Progression I’ve taken a statin…
Pharma Exec Calls a 400 Percent Price Hike ‘Moral.’ Is it?
Is quadrupling the price of a medication “moral”? One pharmaceutical CEO not only thinks so, but he also says it’s…
A Generic for Ampyra Could Be Released Soon
Editor’s note: Shortly after this column was published, Mylan pharmaceuticals announced it will begin distributing Dalfampridine Extended-Release Tablets, 10…
Things to Know About Flu Shots if You Have MS
The start of flu season here in the United States is just a few weeks away. It’s time for…
MS News that Caught My Eye Last Week: B- and T-cells, Tysabri, Sexual Silence
How B-cells Work to Promote T-cell Attacks on Myelin That Lead to MS Detailed in Study I…
Ocrevus Predicted to Be a Billion-dollar Blockbuster
Ocrevus, a disease-modifying MS treatment that’s only been on the market a little less than 18 months, appears poised…